Let’s dig into the relative performance of Dentsply Sirona (NASDAQ:XRAY) and its peers as we unravel the now-completed Q2 ...

A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security ...

In the last three months, 5 analysts have published ratings on Dentsply Sirona (NASDAQ: XRAY), offering a diverse range of perspectives from bullish to bearish.

Potential shareholder lawsuits are swirling around Charlotte-based Dentsply Sirona Inc. since it disclosed an internal investigation into possible securities violations. One law firm is pitching for ...

Fintel reports that on September 26, 2025, Needham reiterated coverage of DENTSPLY SIRONA (NasdaqGS:XRAY) with a Hold ...

This seamless integration of DS Core, Dentsply Sirona’s cloud-based platform, with Second Opinion®, Pearl’s chairside dental AI software, is aimed at enhancing 2D X-ray radiologic accuracy and patient ...

Management reaffirmed the full-year 2025 guidance for organic sales to decline by 2%-4% and adjusted EPS to remain in the range of $1.80 to $2. Reported sales guidance was revised upward to $3.6 ...

DENTSPLY SIRONA Inc. has appointed Daniel Scavilla as President and Chief Executive Officer, effective August 1, 2025, succeeding Simon Campion, who will depart the company on July 31, 2025. Scavilla ...

Dentsply Sirona released preliminary financial results for the second quarter that would have it coming in at or above Wall Street projections. The maker of professional dental products and technology ...

We peg Dentsply Sirona’s XRAY fair value estimate at $28 per share. Our model is underpinned by a 5-year sales CAGR of 3.5% with moderate year-over-year margin expansion and a no-moat rating. Dentsply ...